Skip to main content
Premium Trial:

Request an Annual Quote

Trovagene Q3 Revenues Increase as It Nears Test Launch

NEW YORK (GenomeWeb News) – Trovagene today reported that its third-quarter revenues climbed to $211,000 from $55,000, as the firm nears the launch of its first molecular diagnostic tests.

The San Diego-based firm said that it received a milestone payment of $150,000 during the quarter. It said in August that had achieved an intellectual property milestone under its license agreement with Qiagen subsidiary Ipsogen, triggered by the issuance of a US patent cover the diagnostic use of nucleophosmin protein mutations in patients with acute myeloid leukemia.

It posted a net loss of $650,000, or $.05 per share, for the three months ended Sept. 20, compared to a profit of $9,000, or $.00 per share, for Q3 2011. The third quarter of 2011 included a gain of $623,000 from extinguishment of debt.

Trovagene's R&D spending more than doubled to $511,000 from $201,000, and its general and administrative costs increased to $739,000 from $586,000.

"We are on track to offer our first molecular diagnostic test for the detection of oncogene mutations in the urine of cancer patients as well as a proprietary urine-based HPV test by the end of the year," Trovagene CEO Antonius Schuh said in a statement.

During the quarter, Trovagene licensed to Quest Diagnostics non-exclusive rights to incorporate the nucleophosmin protein (NPM1) into its research and testing services for acute myelogenous leukemia. It also has a deal with Strand Life Sciences to validate and offer its HPV assay in India and countries in the South Asian Association for Regional Cooperation.

Trovagene finished the third quarter with $7.8 million in cash and cash equivalents.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.